Using NLRP3 knockout mice, it has also been reported that NLRP3 inflammasome activation was required for fibrosis development in non-alcoholic fatty liver disease (NAFLD)40. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.